An introduction to gastrointestinal tract CMV disease.

JAAPA

Kevin Michael O'Hara is an assistant professor in the PA program at the Yale School of Medicine in New Haven, Conn. In the PA program at Pace University Lenox Hill Hospital in New York City, Gina Pontrelli is an associate clinical professor and associate director and Katherine L. Kunstel is an assistant clinical professor and director of admissions. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Published: October 2017

Cytomegalovirus (CMV) causes chronic infection that can manifest disease in many organs. The gastrointestinal (GI) tract is a common location for CMV disease. This article reviews the signs, symptoms, diagnosis, treatment, and prevention of GI CMV disease.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JAA.0000524712.40590.76DOI Listing

Publication Analysis

Top Keywords

cmv disease
12
gastrointestinal tract
8
introduction gastrointestinal
4
cmv
4
tract cmv
4
disease
4
disease cytomegalovirus
4
cytomegalovirus cmv
4
cmv chronic
4
chronic infection
4

Similar Publications

Human cytomegalovirus (HCMV) encodes four viral Fc-gamma receptors (vFcγRs) that counteract antibody-mediated activation in vitro, but their role in infection and pathogenesis is unknown. To examine their in vivo function in an animal model evolutionarily closely related to humans, we identified and characterized Rh05, Rh152/151 and Rh173 as the complete set of vFcγRs encoded by rhesus CMV (RhCMV). Each one of these proteins displays functional similarities to their prospective HCMV orthologs with respect to antagonizing host FcγR activation in vitro.

View Article and Find Full Text PDF

Universal cytomegalovirus (CMV) prophylaxis is recommended for at-risk lung transplant recipients. Valganciclovir is currently the preferred first-line agent. Valganciclovir-related myelosuppression, however, can lead to drug discontinuation or reduction in anti-metabolite immunosuppression.

View Article and Find Full Text PDF

Predicting and optimising outcome for biliary atresia.

Semin Pediatr Surg

January 2025

Dept of Paediatric Surgery, Kings College Hospital, London SE59RS, England, United Kingdom. Electronic address:

Biliary atresia (BA) remains a disease of significant morbidity and mortality world-wide. Early and accurate diagnosis facilitates early intervention and improves outcomes. The gold standard in diagnosing BA is a liver biopsy followed by cholangiography, usually performed intra-operatively.

View Article and Find Full Text PDF

Background: Cytomegalovirus (CMV) infection poses a significant risk to kidney transplant recipients. This study investigated CMV disease incidence, outcomes, and management challenges in racial and ethnic minority populations following kidney transplantation.

Methods: This single-center, mixed-methods study included a retrospective cohort analysis of kidney transplant recipients (n = 58) and qualitative surveys of healthcare providers.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates predictors of cytomegalovirus (CMV) infection in immunosuppressed patients with connective tissue disease undergoing pulsed-methylprednisolone (p-MPSL) therapy.
  • It is a retrospective cohort study that analyzed 200 patients' data, identifying key baseline characteristics linked to increased risk of CMV infection, including age, platelet count, lymphocyte count, and specific blood ratio metrics.
  • The findings highlight that older age and low blood cell counts significantly elevate the likelihood of CMV antigen positivity, providing insights for risk assessment in similar patient populations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!